We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Notice for tafasitamab (Specialised Therapeutics Alim Pty Ltd)
Active ingredients
tafasitamab
Date of review outcome
Lapse date
Type
Orphan Drug
Dosage form(s)
powder for solution for infusion
Indication
For the treatment of Diffuse Large B-Cell Lymphoma (DLBCL)
Therapeutic area
Haematology